{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:26:38Z","timestamp":1792427198985,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.schres.2022.02.026","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T06:22:11Z","timestamp":1645856531000},"page":"32-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia"],"prefix":"10.1016","volume":"243","author":[{"given":"Miquel","family":"Bioque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Mezquida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Amoretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemente","family":"Garc\u00eda-Rizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"L\u00f3pez-Ilundain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Covadonga M.","family":"Diaz-Caneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Zorrilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Man\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rodriguez-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iluminada","family":"Corripio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Pomarol-Clotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Usall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"V\u00e1zquez-Bourgon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel J.","family":"Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gonz\u00e1lez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Hidalgo-Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2022.02.026_bb0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1888-9891(09)73233-1","article-title":"Adaptaci\u00f3n y validaci\u00f3n Espa\u00f1ola de la Escala Pron\u00f3stica para la Esquizofrenia de Strauss y Carpenter","volume":"2","author":"Ahuir","year":"2009","journal-title":"Rev. Psiquiatr. Salud Ment."},{"key":"10.1016\/j.schres.2022.02.026_bb0010","article-title":"Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis","author":"Alvarez-Jimenez","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.02.026_bb0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2012.05.007","article-title":"Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies","volume":"139","author":"Alvarez-Jimenez","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.02.026_bb6000","series-title":"DSM-IV: diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association (Washington)","year":"1994"},{"key":"10.1016\/j.schres.2022.02.026_bb0020","series-title":"The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia","year":"2020"},{"key":"10.1016\/j.schres.2022.02.026_bb0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1176\/appi.ajp.2013.12050674","article-title":"Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study","volume":"170","author":"Andreasen","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing\u2014when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.schres.2022.02.026_bb0040","article-title":"The prevention of relapses in first episodes of schizophrenia: the 2EPs project, background, rationale and study design","author":"Bernardo","year":"2020","journal-title":"Rev.Psiquiatr.Salud Ment."},{"key":"10.1016\/j.schres.2022.02.026_bb0045","first-page":"7","article-title":"What have we learned from research into first-episode psychosis?","author":"Bernardo","year":"2014","journal-title":"<sb:contribution><sb:title>Rev. Psiquiatr.<\/sb:title><\/sb:contribution><sb:host><sb:issue><sb:series><sb:title>Salud Ment.<\/sb:title><\/sb:series><\/sb:issue><\/sb:host>"},{"key":"10.1016\/j.schres.2022.02.026_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2017.01.058","article-title":"Modelling gene-environment interaction in first episodes of psychosis","volume":"189","author":"Bernardo","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.02.026_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv121","article-title":"A pharmacovigilance study in first episode of psychosis: psychopharmacological interventions and safety profiles in the PEPs project","volume":"19","author":"Bioque","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2022.02.026_bb0060","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2017.10.030","article-title":"Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis","volume":"195","author":"Bowtell","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.02.026_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2017.11.010","article-title":"Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review","volume":"197","author":"Bowtell","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.02.026_bb0070","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/schbul\/8.3.470","article-title":"Measurement of premorbid adjustment in chronic schizophrenia","volume":"8","author":"Cannon-Spoor","year":"1982","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.02.026_bb0075","article-title":"Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis","author":"Catalan","year":"2020","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0080","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/bmj.38246.594873.7C","article-title":"The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis","volume":"329","author":"Craig","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.schres.2022.02.026_bb0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2019.11.025","article-title":"Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia","volume":"225","author":"Emsley","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.02.026_bb0090","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0095","series-title":"Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II)","author":"First","year":"1997"},{"key":"10.1016\/j.schres.2022.02.026_bb0100","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders - Administration Booklet","author":"First","year":"1994"},{"key":"10.1016\/j.schres.2022.02.026_bb0105","series-title":"Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients","author":"Gasso","year":"2021"},{"key":"10.1016\/j.schres.2022.02.026_bb0110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/schbul\/sbr165","article-title":"A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients: outcome at 30-month follow-up","volume":"39","author":"Gleeson","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"Suppl. 16\u201323","key":"10.1016\/j.schres.2022.02.026_bb0115","article-title":"The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","author":"Haro","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2022.02.026_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1359786810385490","article-title":"Suicide and schizophrenia: a systematic review of rates and risk factors","volume":"24","author":"Hor","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2022.02.026_bb0125","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2215-0366(18)30252-9","article-title":"Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study","volume":"5","author":"Kahn","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/NDT.S96392","article-title":"Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review","volume":"12","author":"Karson","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2022.02.026_bb0135","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.02.026_bb0145","article-title":"Smoking cessation advice for people with serious mental illness","volume":"1","author":"Khanna","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.schres.2022.02.026_bb0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000259089","article-title":"EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence","volume":"1","author":"Kokkevi","year":"1995","journal-title":"Eur. Addict. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2022.02.026_bb0155","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.02.026_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.schres.2022.02.026_bb0165","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0025-7753(02)72429-9","article-title":"Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales","volume":"118","author":"Lobo","year":"2002","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.schres.2022.02.026_bb0170","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1017\/S0033291707002656","article-title":"Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service","volume":"38","author":"Malla","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2022.02.026_bb0175","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4088\/JCP.14m09540","article-title":"Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study","volume":"77","author":"Mayoral-van Son","year":"2016","journal-title":"J.Clin.Psychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2021.04.011","article-title":"Long-term clinical and functional outcome after antipsychotic discontinuation in early phases of non-affective psychosis: results from the PAFIP-10 cohort","author":"Mayoral-van Son","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.02.026_bb0185","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1017\/S0033291714003092","article-title":"Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study","volume":"45","author":"Meer","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2022.02.026_bb0190","series-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica sobre la esquizofrenia y el trastorno psic\u00f3tico incipiente","year":"2009"},{"key":"10.1016\/j.schres.2022.02.026_bb0195","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0200","series-title":"Family Environment Scale: Manual","author":"Moos","year":"1981"},{"key":"10.1016\/j.schres.2022.02.026_bb0205","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/acps.12954","article-title":"Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis","volume":"138","author":"Okhuijsen-Pfeifer","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2022.02.026_bb0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1468-1331.2011.03590.x","article-title":"The economic cost of brain disorders in Europe","volume":"19","author":"Olesen","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.schres.2022.02.026_bb0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0033291713000330","article-title":"Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis","volume":"44","author":"Pelayo-Ter\u00e1n","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2022.02.026_bb0220","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00406-016-0740-3","article-title":"Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)","volume":"267","author":"Pelayo-Ter\u00e1n","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2022.02.026_bb0225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Perala","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0230","first-page":"171","article-title":"Validaci\u00f3n de la escala de los s\u00edndromes positivo y negativo (PANNS) en una muestra de esquizofr\u00e9nicos espa\u00f1oles","volume":"22","author":"Peralta","year":"1994","journal-title":"Actas Luso-Esp Neurol Psiquiatr."},{"issue":"5","key":"10.1016\/j.schres.2022.02.026_bb0235","article-title":"Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder","volume":"3","author":"Rosa","year":"2007","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.schres.2022.02.026_bb0240","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbab063","article-title":"Long-term continuity of antipsychotic treatment for schizophrenia: a nationwide study","author":"Rubio","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.02.026_bb0245","first-page":"627","article-title":"Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis","volume":"4","author":"Schoeler","year":"2017","journal-title":"The LancetPsychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0250","first-page":"1173","article-title":"Association between continued cannabis use and risk of relapse in first-episode psychosis: a quasi-experimental investigation within an observational study","volume":"73","author":"Schoeler","year":"2016","journal-title":"JAMAPsychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.schres.2022.02.026_bb0260","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archpsyc.1972.01750300011002","article-title":"The prediction of outcome in schizophrenia: I. Characteristics of outcome","volume":"27","author":"Strauss","year":"1972","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0265","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41386-018-0278-3","article-title":"Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia","volume":"44","author":"Takeuchi","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2022.02.026_bb0270","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/appi.ajp.2018.17091001","article-title":"20-year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia","volume":"175","author":"Tiihonen","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.02.026_bb0275","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/oxfordjournals.schbul.a033315","article-title":"Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort","volume":"24","author":"Wiersma","year":"1998","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.02.026_bb0280","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.schres.2013.08.001","article-title":"Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review","volume":"152","author":"Zipursky","year":"2014","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422000950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422000950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:44:48Z","timestamp":1760298288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996422000950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":57,"alternative-id":["S0920996422000950"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2022.02.026","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2022.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}